UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 --------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) of the SECURITIES EXCHANGE ACT OF 1934 Date of earliest event reported: July 22, 2003 WEST PHARMACEUTICAL SERVICES, INC. (Exact name of registrant as specified in charter) Pennsylvania 1-8036 23-1210010 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 101 Gordon Drive, P.O. Box 645, Lionville, Pennsylvania 19341-0645 (Address of Principal Executive Offices) (Zip Code) (610) 594-2900 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report) - -------------------------------------------------------------------------------- Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. (c) Exhibits: Exhibit # Description 99.1 West Pharmaceutical Services, Inc. Press Release, dated July 22, 2003. Item 9. Regulation FD Disclosure The following information is furnished pursuant to Item 12, "Disclosure of Results of Operations and Financial Condition." On July 22, 2003 West Pharmaceutical Services, Inc. (the "Company") issued a press release announcing the Company's second quarter financial results for the quarter ended June 30, 2003. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. WEST PHARMACEUTICAL SERVICES, INC. Date: July 22, 2003 By: /s/ Linda R. Altemus ------------------------------- Linda R. Altemus Vice President and Chief Financial Officer Exhibit Index 99.1 West Pharmaceutical Services, Inc. Press Release, dated July 22, 2003.
West Pharmaceutical Services (WST)
Filed: 22 Jul 03, 12:00am